Fake Eli Lilly Twitter Account Claims Insulin Is Free, Stock Falls 4.37%

Forbes - 12 Nov 2022
This week showed what can happen after Elon Musk instituted a new pay $8 and you can get a blue verified check mark from Twitter policy.

Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?

Yahoo Finance - 06 Nov 2024
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried? ...

Yahoo Finance - 08 Nov 2024
...

Eli Lilly brings Memory Cafe to CIIE to raise public awareness about Alzheimer's disease

China Daily - 08 Nov 2024
Eli Lilly brings Memory Cafe to CIIE to raise public awareness about Alzheimer's disease ...

Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more

CNBC - 05 Nov 2024
Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more ...

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

Futurism - 02 Nov 2024
Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro ...

Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products

Investors | Eli Lilly and Company - 30 Oct 2024
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products ...

Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

USA TODAY - 21 Oct 2024
Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound ...

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Fox Business - 16 Oct 2024
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients ...

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

STAT - 11 Oct 2024
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle ...

The Crackdown on Compounded GLP-1 Meds Has Begun

WIRED - 10 Oct 2024
The Crackdown on Compounded GLP-1 Meds Has Begun ...

Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.

The Motley Fool - 08 Nov 2024
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock. ...

Weight loss wars: a century on, the battle heats up

The Australian Financial Review - 08 Oct 2024
Weight loss wars: a century on, the battle heats up ...

Eli Lilly Stock Dives Toward Worst Day Since 2021 On Disappointing Earnings, Zepbound Sales

Forbes - 30 Oct 2024
Eli Lilly Stock Dives Toward Worst Day Since 2021 On Disappointing Earnings, Zepbound Sales ...

Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling

Reuters - 30 Oct 2024
Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling ...

Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly

BioWorld Online - 07 Nov 2024
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly ...

While Novo and Lilly's market value declined in Q3, BMS, Gilead and Sanofi surged: GlobalData

FiercePharma - 08 Nov 2024
While Novo and Lilly's market value declined in Q3, BMS, Gilead and Sanofi surged: GlobalData ...

Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium

Investors | Eli Lilly and Company - 01 Nov 2024
Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium ...

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Yahoo Finance - 05 Nov 2024
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It ...

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

Financial Times - 30 Oct 2024
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales ...

Eli Lilly